Cardiac sympathetic denervation preceding motor signs in Parkinson disease

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • David S. Goldstein - , National Institutes of Health (NIH) (Author)
  • Yehonatan Sharabi - , National Institutes of Health (NIH) (Author)
  • Barbara I. Karp - , National Institutes of Health (NIH) (Author)
  • Oladi Bentho - , National Institutes of Health (NIH) (Author)
  • Ahmed Saleem - , National Institutes of Health (NIH) (Author)
  • Karel Pacak - , Eunice Kennedy Shriver National Institute of Child Health and Human Development (Author)
  • Graeme Eisenhofer - , National Institutes of Health (NIH) (Author)

Abstract

There is substantial interest in identifying biomarkers to detect early Parkinson disease (PD). Cardiac noradrenergic denervation and attenuated baroreflex-cardiovagal function occur in de novo PD, but whether these abnormalities can precede PD has been unknown. Here we report the case of a patient who had profoundly decreased left ventricular myocardial 6-[18F]fluorodopamine-derived radioactivity and low baroreflex-cardiovagal gain, 4 years before the onset of symptoms and signs of PD. The results lead us to hypothesize that cardiac noradrenergic denervation and decreased baroreflex-cardiovagal function may occur early in the pathogenesis of PD.

Details

Original languageEnglish
Pages (from-to)S47-S50
JournalCleveland Clinic journal of medicine
Volume76
Issue numberSuppl 2
Publication statusPublished - 2009
Peer-reviewedYes
Externally publishedYes

Keywords

ASJC Scopus subject areas